II International Symposium: AMR and BEYOND - Antibody-mediated rejection in lung transplantation: how manage and treat patients?
Pulmonary antibody mediated rejection (AMR) after lung transplantation is an important cause of acute and chronic allograft dysfunction. It is critical that the lung transplant clinician, pathologist and immunologist have a strong understanding of the criteria for the diagnosis and assessment of AMR and of the approaches used to manage these patients. Understanding the clinical, pathological and immunological features of AMR will help to close the practice gap in specialist knowledge. We are delighted to offer for the second time this interactive educational opportunity to update the knowledge in this complex diagnostic scenario. The interactive symposium is aimed at experienced lung transplant specialists (Pulmonologists/Respirologists, Surgeons, Pathologists, Immunologists) that should routinely work in a multidisciplinary team for a more sensitive and accurate diagnosis and appropriate management of this complication.
Live Webinar online at www.overgroup.eu
17-11-2020
II International Symposium: AMR and BEYOND - Antibody-mediated rejection in lung transplantation: update in diagnosis
Pulmonary antibody mediated rejection (AMR) after lung transplantation is an important cause of acute and chronic allograft dysfunction. It is critical that the lung transplant clinician, pathologist and immunologist have a strong understanding of the criteria for the diagnosis and assessment of AMR and of the approaches used to manage these patients. Understanding the clinical, pathological and immunological features of AMR will help to close the practice gap in specialist knowledge. We are delighted to offer for the second time this interactive educational opportunity to update the knowledge in this complex diagnostic scenario. The interactive symposium is aimed at experienced lung transplant specialists (Pulmonologists/Respirologists, Surgeons, Pathologists, Immunologists) that should routinely work in a multidisciplinary team for a more sensitive and accurate diagnosis and appropriate management of this complication.
Live Webinar online at www.overgroup.eu
04-11-2020
IV International Conference On: End Stage Lung Diseases (ESLDS) - POST-TRANSPLANT COMPLICATIONS AND NEW RESEARCH LINE
The 4th International Conference on End Stage Lung Diseases (ESLDs) will take place in digital form, on October 27th, November 3rd and 10th, 2020. Based on the success of the previous editions, the scientific organizing committee is excited to launch its 4th theme-based scientific conference. The ESLD conference is a forum of national and international experts who aim to share experiences and outline best management for patients. The ESLDs focus on progressive lung diseases potentially requiring lung transplantation and this year the main theme will be Cystic Fibrosis (CF). The efforts of all transplant specialists are directed towards the improvement of the very complex transplant management of these usually young patients. The novelty of this edition is not only a wide involvement of all the specialists (psychologists, endocrinologists, pneumologists, surgeons, pathologists, immunologists) who play a crucial role in the diagnostic/therapeutic process, but also the participation of patient and family associations.
Live Webinar online at www.surgeryonline.it
10-11-2020